EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects

Romain Manchon, Simon Feys, Martin Hoenigl, Frank L van de Veerdonk, Fanny Lanternier, Joost Wauters, Agostinho Carvalho, Alexandra Serris, Sarah Dellière

Clinical Microbiology and Infection · 2026-05 · 32 (5) · 729-739

DOI: 10.1016/j.cmi.2025.08.030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology and Infection, 2026-05. Verfasst von Romain Manchon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, Immunology of Fungal Infections, Paris, France; Infectious Diseases Department, Necker-Enfants Malades Hospi…. Hauptthemen laut MEDLINE: Host-Pathogen Interactions, Aspergillosis, Aspergillus, Aspergillus fumigatus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Horizon 2020 Framework Programme, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Invasive aspergillosis (IA) remains a major cause of morbidity and mortality in immunocompromised individuals, with an expanding spectrum of at-risk populations, particularly in intensive care settings. Despite advances in antifungal pharmacotherapy, treatment outcomes remain suboptimal, and the rise of antifungal resistance highlights the need for adjunctive therapy that leverages host immune mechanisms. The pathogenesis of IA is primarily driven by impaired or dysregulated immune responses to Aspergillus species, mainly Aspergillus fumigatus. Host defence involves a complex interplay of innate and adaptive, cellular and humoral immune components. However, this response is not only intricate but also heterogenous, challenging the effectiveness of uniform treatment approaches. OBJECTIVES: This review aims to examine the diverse roles of immune components in host-Aspergillus interactions and to explore how these insights are currently informing the development of novel immune-targeted therapies. SOURCES: A thorough analysis of recent and relevant peer-reviewed literature was conducted to synthesize current understanding of Aspergillus-host interactions and the emerging therapeutic strategies derived from these insights. CONTENT: Following a brief overview of the immunopathogenesis of IA, we integrate findings from both preclinical models and clinical studies to evaluate the potential of immune-based therapies as adjuncts to traditional antifungal treatment. Emphasis is placed on the promise of personalized approaches tailored to individual immune profiles. We also address existing knowledge gaps and outline key directions for future research and clinical application. IMPLICATIONS: A deeper understanding of host immunity in IA paves the way for more precise, effective, and personalized therapeutic strategies, with the potential to significantly improve outcomes in vulnerable patient populations. Although still in its early stages, targeted immunotherapy represents an emerging and promising perspective in infectious diseases management. Insights gained from IA may also inform the development of immune-based interventions for other opportunistic infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Host-Pathogen InteractionsAspergillosisAspergillusAspergillus fumigatusHumansAntifungal AgentsImmunocompromised HostAnimalsImmunity, Innate

Stichwörter der Autor:innen

Fungal immunologyFungal infectionsHost-pathogen interactionsImmunocompromised hostImmunotherapyInvasive aspergillosis

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Institut Pasteur, Université Paris Cité, Immunology of Fungal Infections, Paris, France; Infectious Diseases Department, Necker-Enfants Malades Hospital, Université Paris Cité, Assistance Publique - Hôpitaux de Paris (A…
  • Medical Intensive Care Unit, Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Microbiology, Immunology and Transplantation, Katholieke Universiteit (KU) Leuven, Leuven…
  • Department of Internal Medicine, Division of Infectious Diseases, Excellence Center for Medical Mycology, Medical University of Graz, Graz, Austria; BioTechMed Graz, Graz, Austria.
  • Department of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Infectious Diseases Department, Necker-Enfants Malades Hospital, Université Paris Cité, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; European Fungal Infection Study Group, European Society of Clinical…
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; Life and Health Sciences Research Institute (ICVS) / Biomaterials, Biodegradables and Biomimetics Research Gr…

Förderung

  • Agence Nationale de la Recherche
  • Horizon 2020 Framework Programme
  • Fundação para a Ciência e a Tecnologia
  • KU Leuven
  • 'la Caixa' Foundation

Zitieren

APA

Manchon, R., Feys, S., Hoenigl, M., van de Veerdonk, F. L., Lanternier, F., Wauters, J., Carvalho, A., Serris, A., & Dellière, S. (2026). Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects. Clinical Microbiology and Infection, 32(5), 729-739. https://doi.org/10.1016/j.cmi.2025.08.030

Vancouver

Manchon R, Feys S, Hoenigl M, van de Veerdonk FL, Lanternier F, Wauters J, et al. Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects. Clinical Microbiology and Infection. 2026;32(5):729-739. doi:10.1016/j.cmi.2025.08.030

BibTeX
@article{Manchon2026,
  author = {Manchon, Romain and Feys, Simon and Hoenigl, Martin and van de Veerdonk, Frank L and Lanternier, Fanny and Wauters, Joost and Carvalho, Agostinho and Serris, Alexandra and Dellière, Sarah},
  title = {Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  volume = {32},
  number = {5},
  pages = {729--739},
  doi = {10.1016/j.cmi.2025.08.030}
}
Kostenlos starten →